The University of Rochester Medical Center will resume the clinical trial of a potential coronavirus vaccine after it was halted in early September.
The trial of the vaccine, developed by pharmaceutical company AstraZeneca, was stopped after one British participant developed severe neurological symptoms consistent with a rare inflammation of the spinal cord.
Recently, the drug maker got the go-ahead from the U.S. Food and Drug Administration to restart tests in the U.S.